LPM3770164 sustained release tablet simulant

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

8. ハンチントン病

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05238701 (ClinicalTrials.gov)	February 28, 2022	9/1/2022	A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164in Hea ...	A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase I Study to Evaluate the Safe ...	Huntington Disease;Tardive Dyskinesia	Drug: LPM3770164 sustained release tablet;Drug: LPM3770164 sustained release tablet simulant	Luye Pharma Group Ltd.	NULL	Not yet recruiting	18 Years	45 Years	All	104	Phase 1	China

First Previous1Next Last